Grants per year
Fingerprint
Dive into the research topics where Karen Taraszka Hastings is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MHC Class II Antigen Processing and Immune Recognition of Melanoma
Hastings, K. T. (PI)
Project: Research project
-
GILT and regulation of Treg development in cutaneous autoimmunity
Hastings, K. T. (PI)
Project: Research project
-
GILT and regulation of Treg development in cutaneous autoimmunity
Hastings, K. T. (PI)
9/10/13 → 8/31/16
Project: Research project
-
MHC Class II Antigen Processing and Immune Recognition of Melanoma
Hastings, K. T. (PI)
9/1/07 → 8/31/13
Project: Research project
-
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells
Macy, A. M., Herrmann, L. M., Adams, A. C. & Hastings, K. T., Aug 2023, In: Current Opinion in Immunology. 83, 102330.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation
Borden, E. S., Buetow, K. H., Wilson, M. A. & Hastings, K. T., Mar 3 2022, In: Frontiers in Oncology. 12, 836821.Research output: Contribution to journal › Review article › peer-review
Open Access26 Scopus citations -
Corrigendum to “Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest” (Translational Oncology (2022) 15(1), (S1936523321002503), (10.1016/j.tranon.2021.101259))
Adams, A. C., Macy, A. M., Kang, P., Castro-Ochoa, K. F., Wijeratne, E. M. K., Xu, Y. M., Liu, M. X., Charos, A., Bosenberg, M. W., Gunatilaka, A. A. L., Sertil, A. R. & Hastings, K. T., Jul 2022, In: Translational Oncology. 21, 101446.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
Adams, A. C., Borden, E. S., Macy, A. M., Thomson, N., Cui, H., Gimbel, M. I., Wilson, M. A., Buetow, K. H., Roe, D. J., Dicaudo, D. J., Homsi, J. & Hastings, K. T., May 1 2022, In: Cancers. 14, 9, 2200.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens
Borden, E. S., Ghafoor, S., Buetow, K. H., LaFleur, B. J., Wilson, M. A. & Hastings, K. T., Apr 1 2022, In: Journal of Immunology. 208, 7, p. 1813-1827 15 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations